miRNAs |
Cancer type |
Body fluid source |
Clinical correlations |
Reference |
miR-335 |
Breast |
Serum |
Overexpressed miR-335 were associated with breast cancer histological tumor grades and hormone receptor expression status |
[20] |
miR-24 |
Ovarian
BreastColorectal |
Plasma
Serum
Plasma |
Lower levels ofmiR-24in patients than controlsIncreased serum level of miR-24 in Breast Cancer patients.
Decreased plasma levels of miR-24serve as novel biomarkers for early stage detection of colorectal |
[21-23] |
miR-320 |
Breast |
Serum |
Underexpressed in the serum of women who developed lymph node-positive breast tumors. |
[24] |
miR-548d-5p |
Bladder |
Urine |
Expressed predominantly in patients with higher cancer stages |
[24] |
miR-342-5p |
Ovarian |
Whole blood |
Decreasedlevels in ovarian cancer |
[25] |
miR-15a |
Breast |
Serum |
Increased serum level in older compared to young breast patients |
[26] |
miR-342-3p |
Breast |
Serum |
High serum level in older compared to young breast patients |
[27] |
miR-29a |
Colorectal |
Plasma |
Increasedplasma levels in advanced-stage cancer than controls miR29a correlates with tumor stage |
[28] |
miR-451 |
Breast |
Plasma |
Increased plasma level found in breast cancer patients |
[29] |
miR-30b |
Breast |
Serum |
high levels in the serum of breast cancer patients than control subjects |
[16] |
miR-337-5p |
ESCC |
Serum |
Serum levels were differentially expressed between ESCC patients and controls |
[30] |
miR-486-3p |
ProstateBreast |
Serum |
Serum levels were significantly higher in patients compared to controls. Increased serum levelin older versus young breast cancer patients |
[27-32] |